Counting the neurological cost of COVID-19

The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mor...

Descripción completa

Detalles Bibliográficos
Autor principal: Baig, Abdul Mannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600497/
https://www.ncbi.nlm.nih.gov/pubmed/34795449
http://dx.doi.org/10.1038/s41582-021-00593-7
Descripción
Sumario:The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.

Ejemplares similares